Babson Life Sciences Entrepreneurial Product Development Immersion for New Technologies and Solutions (Babson L-SPRINT) Program

NIH RePORTER · NIH · UE5 · $107,895 · view on reporter.nih.gov ↗

Abstract

Project Summary/Abstract The ability to coordinate or match drug addiction scientists with business, regulatory, and financing experts (referred to as ‘entrepreneurial leaders’) is key to establishing societal and commercial solutions in this subject area. Having a database to search for specific characteristics or knowledge, and a platform to identify and introduce potential partners in is expected to lead to longer associations and startup success. SUD companies may require some different skill sets, e.g., public health’s focus on the social determinants of health, or public finance and non-profit management, and thus finding a way to match academic researchers with entrepreneurial leaders interested in startups that tackle drug addiction is key to establishing successful ventures. We will also generate and track possible measures of success including networking metrics and publish findings on these associated metrics. Again, with specific reference to SUD ventures, we will hypothesize metrics that may be associated with success and publish the empirical data found to be most important for startup success in drug addiction.

Key facts

NIH application ID
11002151
Project number
3UE5DA056894-02S1
Recipient
BABSON COLLEGE
Principal Investigator
Wiljeana Glover
Activity code
UE5
Funding institute
NIH
Fiscal year
2024
Award amount
$107,895
Award type
3
Project period
2022-08-15 → 2027-06-30